BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 24333384)

  • 21. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases.
    Gensollen T; Bourges C; Rihet P; Rostan A; Millet V; Noguchi T; Bourdon V; Sobol H; Dubuquoy L; Bertin B; Fumery M; Desreumaux P; Colombel JF; Chamaillard M; Hebuterne X; Hofman P; Naquet P; Galland F
    Inflamm Bowel Dis; 2013 Oct; 19(11):2315-25. PubMed ID: 23949622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population.
    Jung ES; Kim SW; Moon CM; Shin DJ; Son NH; Kim ES; Lee HJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Life Sci; 2011 Aug; 89(9-10):289-94. PubMed ID: 21763322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IBD candidate genes and intestinal barrier regulation.
    McCole DF
    Inflamm Bowel Dis; 2014 Oct; 20(10):1829-49. PubMed ID: 25215613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variant-to-Gene-Mapping Analyses Reveal a Role for the Hypothalamus in Genetic Susceptibility to Inflammatory Bowel Disease.
    Lasconi C; Pahl MC; Cousminer DL; Doege CA; Chesi A; Hodge KM; Leonard ME; Lu S; Johnson ME; Su C; Hammond RK; Pippin JA; Terry NA; Ghanem LR; Leibel RL; Wells AD; Grant SFA
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):667-682. PubMed ID: 33069917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
    Bai AH; Wu WK; Xu L; Wong SH; Go MY; Chan AW; Harbord M; Zhang S; Chen M; Wu JC; Chan MW; Chan MT; Chan FK; Sung JJ; Yu J; Cheng AS; Ng SC
    J Crohns Colitis; 2016 Jun; 10(6):726-34. PubMed ID: 26802082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases].
    Bouma G; Peña AS
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2414-20. PubMed ID: 10608975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
    Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
    Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic background of inflammatory bowel disease: from correlation to causality.
    Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
    J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.
    Parmar AS; Lappalainen M; Paavola-Sakki P; Halme L; Färkkilä M; Turunen U; Kontula K; Aromaa A; Salomaa V; Peltonen L; Halfvarson J; Törkvist L; D'Amato M; Saavalainen P; Einarsdottir E
    Genes Immun; 2012 Sep; 13(6):474-80. PubMed ID: 22592522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model.
    Chen M; Li Q; Cao N; Deng Y; Li L; Zhao Q; Wu M; Ye M
    Mol Omics; 2019 Aug; 15(4):296-307. PubMed ID: 31147658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease.
    Raine T; Liu JZ; Anderson CA; Parkes M; Kaser A
    Gut; 2015 Feb; 64(2):250-9. PubMed ID: 24799394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
    McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
    Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INFERNO: inferring the molecular mechanisms of noncoding genetic variants.
    Amlie-Wolf A; Tang M; Mlynarski EE; Kuksa PP; Valladares O; Katanic Z; Tsuang D; Brown CD; Schellenberg GD; Wang LS
    Nucleic Acids Res; 2018 Sep; 46(17):8740-8753. PubMed ID: 30113658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial Aneurysm-Associated Single-Nucleotide Polymorphisms Alter Regulatory DNA in the Human Circle of Willis.
    Laarman MD; Vermunt MW; Kleinloog R; de Boer-Bergsma JJ; Brain Bank N; Rinkel GJE; Creyghton MP; Mokry M; Bakkers J; Ruigrok YM
    Stroke; 2018 Feb; 49(2):447-453. PubMed ID: 29301971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.